World Cancer Day - celebrating cancer research at Bristol
29 January 2019
This World Cancer Day we are highlighting the work of Bristol Cancer Network at the University of Bristol, a multidisciplinary research community dedicated to finding new breakthroughs against cancer.
World Cancer Day is about creating a future without cancer, the target: to reduce premature cancer deaths and deaths from non-communicable diseases by 25% by 2025. They identify ‘high quality data and research’ and ‘early detection and diagnosis’ as two of four campaign pillars to help achieve this goal.
Bristol Cancer Network, supported by Elizabeth Blackwell Institute, is a vibrant cross-disciplinary community, which aims to accelerate the identification and translation of research into clinical practice for the early detection and treatment of cancer. It focuses on core strengths in cancer cell biology, genetic and lifecourse epidemiology and health services research to enhance early diagnostics, screening and prevention of a variety of cancers.
Prevention and early detection for cancer are emphasised in the NHS Long Term Plan and the University of Bristol is already aligning its research in this area, working to reduce the burden of cancer through prevention and early diagnosis. Richard Martin, Professor of Clinical Epidemiology, and Caroline Relton, Professor of Epigenetic Epidemiology lead the Integrative Cancer Epidemiology Programme (ICEP), a major 5-year programme funded by Cancer Research UK, to identify modifiable risk factors for developing cancer and gene targets that could be exploited for drug prevention; categorise the interaction between genes and environmental factors in the development of cancer; and isolate blood-based biomarkers for cancer risk prediction. Read more about their research.
The University of Bristol works in partnership with Bristol NHS Trusts and the University of West of England (UWE) on cancer research.
Dr Axel Walther MA PhD FRCP, Consultant Medical Oncologist; Director for Research, Bristol Cancer Research; and Co-Lead for Bristol Cancer Network, said: “Having a world class University on your doorstep facilitates the interaction between scientists and clinicians, and the coherent cross-disciplinary community is the ideal vehicle for new ideas on how to understand and treat cancer better.”
Prof Paul Martin PhD FMedSci, Professor of Cell Biology, Co-Lead Bristol Cancer Network said: “What has been so beneficial about our Cancer Network has been the bringing together of disparate disciplines in our Bristol community from engineers modelling delivery of nanoparticle therapeutics through to basic scientists imaging cancer immunity in model organisms and onto clinicians treating real patients with cancer; most cancer Institutes don’t offer this breadth of approach and we feel that these interactions between us, which we catalyse with regular ‘show and tell’ meetings, will provide us with novel insights for early detection and curing of cancer."
Download the new booklet for Bristol Cancer Network to find out more about research for cancer at Bristol University.
You can see programme for the Cancer Research Network’s Show & Tell event which took place on 9 January 2019 to see who presented and what topics were discussed: http://www.bristol.ac.uk/cancer/events/2019/showtell-9jan.html
The next Bristol Cancer Network event is likely to be held in late June with the theme expected to be translation: from basic science to the clinic – watch this space.
Keep up to date with Cancer research at Bristol by subscribing to the Bristol Cancer Network newsletter: http://www.bristol.ac.uk/cancer/newsletters/
Bristol Cancer Network events: http://www.bristol.ac.uk/cancer/events/